Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Coronary Disease

• Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
• A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
• A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)
• Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
• Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease
• A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease
• Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
• Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy
• High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program
• Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy
• Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
• Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)
• A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease
• Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
• Influence of Anesthetics on Clinical Outcome During Cardiac Surgery in Adults
• Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease
• HOST - DAPT Duration According the Bleeding Risk
• Impact of Colchicine on Peri-Operative Major Adverse Cardiovascular Events in Patients With Prior Coronary Revascularization: The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
• Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
• Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
• Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting
• A Comparison Between Ketamine-lidocaine Versus Ketamine-fentanyl for Induction on the Hemodynamic Effects in Patients With Coronary Artery Disease
• HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation
• Comparing the Hemodynamic Effects of Volume Loading vs Non-loading During Induction of Anesthesia in Fluid Responder Patients With Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Graft Surgery: a Randomized Controlled Study.
• A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
• Influence of Lipid Lowering on Impaired Coronary Flow
• Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previou
• Colchicine in Decrease of Perivascular Inflammation Index on Coronary CTA: A Randomized Open-label Trial
• Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
• Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel
• Trained Immunity by Dual-pathway Inhibition in Coronary Artery Disease
• Colchicine Use for Primary Prevention of Coronary Artery Disease
• The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
• A Phase I Study to Evaluate XTR003 in Chinese Healthy Volunteers
• RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial Flow
• A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
• SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)
• the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
• Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
• Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
• Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Reduced Ejection Fraction (Syndrome of Qi Deficiency and Blood Stasis) Due to Coronary Heart Disease
• Effect of MUSK Pill on the Patients With Chest Pain Due to Non Obstructive Coronary Artery Disease
• Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
• Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
• Influence of Oxygen on Perioperative Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery
• Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
• Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)
• Effect of Evolocumab on Coronary Plaque Characteristics
• Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
• Coronary Hemodynamics by Coronary Angiography
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles
• Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment
• 18F-FMPP PET MPI in the Detection of Coronary Artery Disease
• The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
• iSGLT2 in Prevention of Acute Kidney Injury in Patients With Diabetes Mellitus Undergoing CABG Extracorporeal On-Pump
• A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.
• Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
• Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
• Myocardial Strain Analysis in Anaesthetized Coronary Artery Disease Patients During Hyperoxia and Normoxaemia
• Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD
• Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
• Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
• Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease
• Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
• A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
• Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
• Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris
• Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)
• Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation With Stabilized Coronary Artery Disease
• The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
• Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles
• Fastigial Nucleus Stimulation for Coronary Heart Disease
• Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery
• Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)
• Effect of Empagliflozin on Ventricular Repolarization.
• The CHORAL Flow Study
• LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
• Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy
• Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery
• The PATHFINDER Study: A Feasibility Trial
• Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
• Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
• Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
• Nitrite Effects on Cardiac Muscle in CABG
• How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: A Serial CT Study
• Semaglutide Treatment On Coronary Progression
• 1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials
• A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
• Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease
• Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery
• The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery
• Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
• Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
• A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
• A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
• Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)
• Enhanced Recovery After Cardiac Surgery
• A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4
• The Recovery of Cardiovascular Patients With Depression
• The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
• The Val-CARD Trial
• XIENCE 28 USA Study
• Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial
• SAPT Versus DAPT in Incomplete Revascularization After CABG
• Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
• The Randomized OPTIMAL-ACT Trial
• The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes
• Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
• Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND
• Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
• Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies
• Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
• Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
• Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
• DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
• Optical Coherence Tomography-guided Coronary Intervention and Optimal Use of Dual Anti-Platelet Therapy In Patients With Complex Lesions (OCCUPI Trial)
• Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
• Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
• SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
• Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
• The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
• Coronary Artery Disease After Heart Transplantation
• The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
• Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
• Imaging of Coronary Plaques in Participants Treated With Evolocumab
• Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)
• The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography
• TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery
• Dabigatran Versus Warfarin With NVAF Who Undergo PCI
• Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound
• Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
• Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat
• Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)
• Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
• Effect of Evolocumab on Coronary Endothelial Function
• Coronary Angiography THerapeutic Virtual Reality
• Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
• Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation
• Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery
• Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
• Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus
• Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
• Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
• Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
• A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
• Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction
• Peripheral Nerve Blocks for Above-the-knee Amputations
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
• Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease
• Uric Acid Effects on Endothelium and Oxydative Stress
• Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction
• Allopurinol and Endothelial Function in Diabetic CAD Patients
• A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
• PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
• Efficacy and Safety of Low-dose Ticagrelor
• Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
• Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease
• The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease
• Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics
• XIENCE 28 Global Study
• An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
• AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
• Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
• Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept
• Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
• Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease
• Low Dose Statins, Ezetimibe and Nutraceuticals
• Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride
• Liraglutide Effects on Epicardial Fat Inflammatory Genes
• Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients
• A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI
• Expression Profiling of microRNA Following Administration of Dexmedetomidine
• Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris
• Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial
• CES1 Carriers in the PAPI Study
• STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation
• Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine
• VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography
• Usual Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque
• Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)
• P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
• Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT
• Efficacy of Enhanced External Counterpulsation on Ventricular Function
• IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease
• Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
• Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
• Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention
• Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI
• Local Anesthesia in Radial Catheterization
• Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity
• Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
• Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris
• Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
• Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
• Alirocumab and Reverse Cholesterol Transport
• Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
• Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
• Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
• ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial
• Genomic Outcomes of Metformin
• Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
• A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718
• Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
• Efficacy and Safety of Aspirin Therapy With CABG
• Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery
• Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease
• Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
• Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.
• Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
• The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
• High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
• 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
• Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
• Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
• Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
• Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
• Coronary Artery Disease Progression in Patients With Prediabetes
• Clopidogrel Versus Ticagrelor in Type-2 Diabetes
• Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG
• COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
• A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"
• Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements
• Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
• The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
• Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease
• GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
• A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
• Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
• What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
• Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
• Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients
• Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
• ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
• Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease
• Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease
• EVOLVE Short DAPT Study
• Colchicine in Percutaneous Coronary Intervention
• Effect of Rosuvastatin Therapy on HDL2 Level
• Ezetimibe and Atorvastatin Therapy on TCFA
• Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
• Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease: a Randomized Comparison Trial
• The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
• Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
• Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
• Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
• Colchicine Cardiovascular Outcomes Trial (COLCOT)
• Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
• Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
• Clinical Study On The Relation Among Prescription, Syndrome and Disease of Turbid Phlegm and Blood Stasis for Coronary Heart Disease
• Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
• Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
• ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts
• Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease
• Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel
• Ivabradine and Post-revascularisation Microcirculatory Dysfunction
• Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
• Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
• Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting
• Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
• Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
• Contrast Enhancement on Coronary Computed Tomographic Angiography
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
• Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
• Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease
• Plasma and Platelet microRNAs in Clopidogrel Low Response Patients
• Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure
• Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
• Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
• Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
• Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
• The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus
• Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
• Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease
• Simplified Anti-Thrombotic Therapy for FFR
• Reversal of the Anti-platelet Effects of Ticagrelor
• Metformin for HIV Inflammation
• Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
• GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
• Inflammation and Coronary Endothelial Function
• Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery
• The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
• Effects of Linagliptin on Endothelial Function
• Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min).
• Leaders Free Japan
• Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
• Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
• STEEL Percutaneous Coronary Intervention
• Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients
• The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque
• Liraglutide to Improve corONary Haemodynamics During Exercise streSS
• Xience Versus Synergy in Left Main PCI
• Comparison of Biomatrix and Orsiro Drug Eluting Stent
• Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
• Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
• Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
• NIRS Ticagrelor Evaluation
• the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
• Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
• Ranolazine Among Unrevascularized Chronic Stable Angina Patients
• BFPET for Regional Myocardial Perfusion Imaging
• Eliminate Coronary Artery Disease
• Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
• Impact of Breathing Maneuvers on the Oxygenation Supply of the Heart Assessed With MRI in Patients With Coronary Artery Disease
• Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
• MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease
• Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
• Pharmacological Effects of Crushing Prasugrel in STEMI Patients
• Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery
• Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
• Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty
• Reversing Ticagrelor's Effects With Fresh Platelets
• DES Versus BiOSS LIM - POLBOS II Study
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
• Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress
• CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)
• Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
• COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial
• Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes
• GLP-1 Loading During Elective Percutaneous Coronary Intervention
• Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
• A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery
• DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
• The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease
• A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function
• Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol
• Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
• Plant Sterols Effect on Previous Statin Therapy
• In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
• Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES
• Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
• Prasugrel With Lower Dose - Loading Dose
• A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
• Ticagrelor China Pharmacokinetic/Pharmacodynamic Study
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
• 123I-mIBG SPECT Imaging
• Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)
• "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-
• Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
• Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
• Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
• Arginase Inhibition in Ischemia-reperfusion Injury
• Assessment Of Vascular Health After Niacin Therapy (AVANT)
• Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients
• ISCHEMIA-Chronic Kidney Disease Trial
• Study of the Vascular Effects of Serelaxin
• Cangrelor to Clopidogrel or Prasugrel Transition Study
• Stress CT Perfusion in Patients With Chest Pain
• Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention
• Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
• Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery Bypass
• Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease
• Atrial Fibrillation and By-pass Surgery
• OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
• Effect of Probiotic Supplementation on Endothelial Function
• Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies
• Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.
• Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
• The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease
• Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study
• High Ticagrelor Loading Dose in STEMI
• A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
• Ranitidin Versus Omeprazole in Patients Taking Clopidogrel
• Ticagrelor vs Clopidogrel Effect on MFR in CAD Population
• Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
• Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
• Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
• Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
• A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
• Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
• Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
• Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
• Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
• Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
• Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease
• Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
• Cangrelor Prasugrel Transition Study
• Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
• A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
• Phase Analysis and Obstructive CAD on Rubidium PET
• YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
• Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
• Parasternal Nerve Block in Cardiac Patients
• CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects
• Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
• Propofol Effects on Mitral Valve Annular Velocity
• Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
• Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Impact of Ranolazine on Coronary Microcirculatory Resistance
• Pharmacogenomics of Antiplatelet Response - I
• GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
• Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
• Regadenoson and Adenosine
• Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients
• Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
• Effect of Ticagrelor on Endothelial Function
• Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia
• Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
• Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery
• Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
• Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
• Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
• The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques
• Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease
• Cangrelor Ticagrelor Transition Study
• Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
• The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina
• Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin
• A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient
• Xenon in Off-pump Coronary Artery Bypass Graft Surgery
• Comparison of Efficacy of Ivabradine Versus Metoprolol
• Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
• Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
• Statin and Post-interventional Coronary Microcirculation Dysfunction
• Tailored Antiplatelet Therapy Following PCI
• Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
• Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
• Statin Recapture Therapy Before Coronary Artery Bypass Grafting
• Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
• Anti-inflammatory Effects of Colchicine in PCI
• Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
• Dexmedetomidine's Cardiac and Cognitive Influence on Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
• Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
• Physical and Chemical Study of Atherosclerosis Mechanisms
• Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
• Fenoldopam for Prevention of Acute Kidney Injury
• Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
• Fluvastatin AmelIorates aTHerosclerosis Study
• Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
• A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease
• The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.
• Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination
• Short and Optimal Duration of Dual Antiplatelet Therapy Study
• Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
• The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion
• Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
• Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
• PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity
• Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
• Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study
• Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation
• SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)
• The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients
• Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
• Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft
• A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
• The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
• Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
• A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• Physiological Study of Human Cholesterol Metabolism and Excretion
• The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
• Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation
• The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
• ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
• PROMUS Element Plus US Post-Approval Study
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
• Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
• Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
• Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting
• Effect of PADMA 28 on Endothelial Function, Autonomic Nervous System and Biomarkers in Patients With Coronary Artery Disease
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
• Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease
• Vitamin D Repletion in Coronary Artery Disease
• Local Thrombolytics Before Thrombectomy in STEMI
• Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
• Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
• Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease
• Safety of Amiodarone and Ranolazine Together in Patients With Angina
• A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers
• Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
• Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
• Saxagliptin and Atherosclerosis
• Relationship Between the Menstrual Cycle and Heart Disease in Women
• High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients
• 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
• A Pharmacodynamic Study With Ticagrelor in African American Patients
• A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
• Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery
• A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
• Nobori Dual Antiplatelet Therapy as Appropriate Duration
• A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis
• The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols
• PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
• The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease
• Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)
• Tirofiban in Stenting for Long Coronary Lesion
• Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
• The Cortisol Levels During Cardiac Surgery. The Comparison Between Etomidate and Thiopentone
• N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy
• Ranolazine Loading to Prevent PCI-induced Myocardial Injury
• Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
• Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
• Regadenoson Real Time Perfusion Imaging Trial-Optison
• Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
• Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass
• Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery
• Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
• Efficacy of LCQ908 on Cardiovascular Risk
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
• Prevention of Serious Adverse Events Following Angiography
• Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
• Hypertonic Solution in Off Pump Coronary Artery Bypass Graft Surgery
• Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
• The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
• Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
• Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
• Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
• Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
• Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)
• A Prospective Study to Evaluate the Effect of Chronic Nitrate Therapy on Vasodilation Function in Coronary Heart Disease
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
• Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
• The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
• Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
• Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease
• Is Verapamil In TransRadial Interventions OmittabLe?
• Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
• Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
• Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)
• Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
• Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
• Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
• Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery
• Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
• Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
• Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress
• Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
• Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
• Comparison of Heparin Types; Efficacy and Safety
• The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
• A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
• A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
• Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients
• The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris
• A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
• Ranibizumab and the Risk of Arterial Thromboembolic Events
• Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery
• Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
• Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
• Influence of Varenicline on the Antiplatelet Action of Clopidogrel
• Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
• Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment
• Ranolazine, Ethnicity and the Metabolic Syndrome
• A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)
• Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
• Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
• Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
• Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
• A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
• RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
• Investigation of the Athero-Protective Effects of Clopidogrel
• The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
• The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
• Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
• A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
• Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation
• Treatment of Coronary Heart Disease With Amiloride
• Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound
• Novel Treatment for Coronary Artery Disease
• Metformin to Reduce Heart Failure After Myocardial Infarction
• Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
• Aspirin Dosing in Diabetic Patients
• Prasugrel Re-load Strategies
• Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
• Screen of DM by OGTT in Subjects Receiving CAG or MDCT for CAD
• Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease
• Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation
• Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease
• Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)
• Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia
• Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
• Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery
• Stenting of Renal Artery Stenosis in Coronary Artery Disease Study
• Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery
• Coronary Vasomotor Response After Riociguat Exposure
• Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia
• Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
• A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization
• Comparison of Generic and Original Formulation of Clopidogrel
• Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
• Niacin/Laropiprant and Endothelial Function
• Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
• A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients
• Pilot Study on the Effect of High Clopidogrel Maintenance Dosing
• An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
• Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial
• Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
• Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
• Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease
• Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
• Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
• Clopidogrel/Aspirin Interaction Study
• Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
• Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
• Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
• A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
• EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
• Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
• Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
• EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
• The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome
• ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
• Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion
• Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
• Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
• The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients
• Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
• Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)
• Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease
• Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease
• Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)
• The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance
• Pilot Study of Organic Nitrates on Endothelial Function in CAD Patients
• Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
• Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
• Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging
• Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)
• Clopidogrel Proton-Pump Inhibitors Study
• Prasugrel/Clopidogrel Maintenance Dose Washout Study
• Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
• Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
• Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
• Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
• Efficacy and Safety Study on bIAP
• Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol
• PGD2 Formation in Vascular Injury
• Statin and Atheroma Vulnerability Evaluation
• TAXUS Libertē Post Approval Study
• Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
• Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
• Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
• Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus
• Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
• The Dual Antiplatelet Therapy Study (DAPT Study)
• Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
• Fibrinogen and Bleeding After Cardiac Surgery
• Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
• Ezetimibe in Patients Hypo-responsive to Statins
• Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
• Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
• CYPRESS - CYPHER for Evaluating Sustained Safety
• Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine
• Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
• Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
• Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
• Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
• Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease
• Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects
• Study of [3H] BMS747158 in Healthy Male Subjects
• Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)
• Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease
• Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
• Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
• Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180
• Stress Echocardiography Study With Regadenoson
• Alternative in Beta Blocker Intolerance: The ABBI Trial
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Stress Testing and Cardiac Magnetic Resonance
• Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
• Phytosterols, Ezetimibe, and Cholesterol Metabolism
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
• Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)
• Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)
• Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
• PET/CT Study in the Diagnosis of Coronary Plaque
• Clopidogrel Resistance and the Possibility of Its Affection
• Regadenoson R-T Perfusion Imaging Trial
• Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy
• Acarbose Cardiovascular Evaluation Trial
• Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy
• Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
• Clopidogrel and Response Variability Investigation Study 2
• Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
• Milrinone Inhaled in Cardiac Surgery
• Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
• Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
• Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)
• Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
• Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
• Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
• The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery
• The Efficacy of CILostazol ON Ischemic Complications After DES Implantation
• Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation
• Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.
• Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients
• Persantin Preceding Elective PCI
• Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
• Persantine: Variation in Response Trial
• Aspirin Resistance in Coronary Artery Disease
• The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin
• Uric Acid Study in Healthy Male Volunteers
• Darusentan Effect on PET Uptake Heterogeneity
• Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
• A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET
• Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
• Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <> (Study P05464)
• The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness
• Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
• Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.
• Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.
• Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
• Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
• Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI
• Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
• Shanghai Registry of Acute Coronary Events
• Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease
• Telmisartan Versus Ramipril After Acute Coronary Syndrome
• Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
• Healthy Volunteer Study of Clopidogrel and Rifampicin
• Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
• Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function
• Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
• Risk Reduction in Coronary Heart Disease
• The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease
• Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study
• Anticoagulant Treatments and Percutaneous Coronary Angioplasty
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
• Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
• A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
• Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
• Vitamins in Nitrous Oxide Study
• A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
• A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
• Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks
• Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
• Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
• Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
• United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study
• The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
• A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
• Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)
• Pycnogenol and Endothelial Function in Coronary Artery Disease
• Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
• Targeting Inflammation Using Salsalate in CardioVascular Disease
• RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome
• Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
• Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis
• Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
• The RAS, Fibrinolysis and Cardiopulmonary Bypass
• Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes
• Filgrastim for the Promotion of Collateral Growth in Patients With CAD
• Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007
• Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease
• Familiarization and Safety Study of PB127 Ultrasound Contrast Agent
• Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women
• Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
• Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
• Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents
• Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent
• Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
• Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
• Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
• Microvascular Coronary Disease In Women: Impact Of Ranolazine
• Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
• Safety of High-dose Tirofiban During Coronary Angioplasty
• The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease
• Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
• Study of ONO-1101 in Patients Scheduled for Coronary Angiography
• Coronary MDCTA With Iopamidol Injection 370
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
• Sulfasalazine and Endothelial Function
• Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease
• Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
• A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)
• Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
• Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
• A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease
• A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-1
• Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease
• sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial
• An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)
• Desflurane Versus Propofol Anesthesia for Off-Pump CABG
• A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
• PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
• 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
• Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia
• Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
• Intravenous Fish Oil in Critically Ill Cardiac Patients
• Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
• Platelet Function Assessment for Atherothrombotic Patients
• Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
• Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease
• Glutamate for Metabolic Intervention in Coronary Surgery
• Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
• Association of Clopidogrel Therapy and Stent Thrombosis
• Comparison Between Pioglitazone and SES With type2 DM
• Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons
• Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
• Early Cardioprotective Effect of Sevoflurane
• Effect of Celecoxib on Markers of Vascular Inflammation
• Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
• Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
• PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
• The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
• Cholesterol and Pharmacogenetic Study
• Antithrombotic Regimens and Outcome
• Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
• Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)
• Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction
• Enoxaparin Versus Unfractionated Heparin in PCI
• A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis
• H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel
• Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
• The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial
• Endothelin-Receptor Blockade in Coronary Heart Disease
• Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
• The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
• Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
• Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
• Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery
• Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
• The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
• Rilonacept to Improve Artery Function in Patients With Atherosclerosis
• Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery
• A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease
• The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
• Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
• The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention
• Lipid Lowering in Patients With Statin Intolerance
• A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
• RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
• Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.
• Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
• Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
• Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
• Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
• Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
• A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
• The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
• Study Effect of VIA-2291 on Vascular Inflammation
• Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting
• WENBIT - Western Norway B Vitamin Intervention Trial
• A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
• Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
• Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
• Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
• Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
• Effects of Atorvastatin on Myonecrosis
• Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
• Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
• Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS
• Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
• Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography
• Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study
• Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
• The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
• A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
• Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
• Intensive Glycemic Control and Skeletal Health Study
• LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
• Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen
• Heart and Estrogen-Progestin Replacement Study (HERS)
• Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
• Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
• RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)
• Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
• Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease
• Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT
• Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition
• A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
• Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
• Effect of Folic Acid Treatment in Coronary Artery Disease
• Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)
• A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention
• Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clin
• Cell Therapy for Coronary Heart Disease
• Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease
• TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality
• Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
• The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
• The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
• Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
• Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism
• SB-480848 In Subjects With Coronary Heart Disease
• Integrated Biomarker And Imaging Study - 2
• Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary Angioplasty
• Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
• MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery
• Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
• A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
• Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery
• MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting
• Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
• Reducing Total Cardiovascular Risk in an Urban Community
• Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)
• Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
• Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
• Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
• Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
• Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
• Acarbose and Secondary Prevention After Coronary Stenting
• "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
• Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery
• Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography
• Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
• ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
• ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
• A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
• Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
• Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
• Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
• Fluvastatin in the Therapy of Acute Coronary Syndrome
• EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study
• Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
• EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
• A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
• Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
• The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
• 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
• Endothelial Modulation for Angiogenic Therapy
• A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
• A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
• INVEST: INternational VErapamil SR Trandolapril STudy
• Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
• Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
• Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass
• Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
• Niacin Plus Statin to Prevent Vascular Events
• Electrophysiological Effects of Late PCI After MI
• Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
• MARS - Monitored Atherosclerosis Regression Study
• Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
• BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
• Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
• CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
• A Safety Study of ABI-007 for In-Stent Restenosis
• An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)
• Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
• Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
• IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
• Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease
• Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)
• Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
• Estrogen, HDL, and Coronary Heart Disease in Women
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
• Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
• ARISE - Aggressive Reduction of Inflammation Stops Events
• A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
• MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)
• Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
• Trial to Assess Chelation Therapy (TACT)
• Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
• Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
• Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
• Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
• Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)
• Azithromycin and Coronary Events Study (ACES)
• CVD Risk and Health in Postmenopausal Phytoestrogen Users
• Women's Health Initiative (WHI)
• Magnesium in Coronaries (MAGIC)
• Estrogen and Graft Atherosclerosis Research Trial (EAGER)
• Postmenopausal Hormone Therapy in Unstable Angina
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• NHLBI Type II Coronary Intervention Study
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
• Women's Angiographic Vitamin and Estrogen Trial (WAVE)
• HDL-Atherosclerosis Treatment Study (HATS)
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
• Estrogen Replacement and Atherosclerosis (ERA) in Older Women
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
• Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
• Tamoxifen Study
• Cardiac Arrhythmia Suppression Trial (CAST)
• Studies of Left Ventricular Dysfunction (SOLVD)
• Familial Atherosclerosis Treatment Study
• Platelet-Inhibitor Drug Trial in Coronary Angioplasty
• Intravenous Streptokinase in Acute Myocardial Infarction
• Thrombolysis in Myocardial Infarction (TIMI)
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
• Physicians' Health Study
• Platelet Drug Trial in Coronary Disease Progression
• Multicenter Investigation of Limitation of Infarct Size (MILIS)
• Beta-Blocker Heart Attack Trial (BHAT)
• Aspirin-Myocardial Infarction Study (AMIS)
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
• Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
• Coronary Drug Project Mortality Surveillance
• Coronary Drug Project
• Multicenter Unsustained Tachycardia Trial (MUSTT)
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
• Cholesterol Reduction in Seniors Program (CRISP)
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)
• Myocardial Infarction Triage and Intervention Project (MITI)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)
• Post Coronary Artery Bypass Graft (CABG) Study
• Harvard Atherosclerosis Reversibility Project (HARP)